musculoskeletal

Chronic joint pain

Aggregated cohort reports for joint pain protocols. Read alongside conventional care, not in place of it.

Outcomes this condition tracks

Why certain peptides surface — weighted by clinical relevance.

  • Tissue & joint repair

    weight 1.00

    BPC-157 / TB-500 cohort reports on cartilage and soft-tissue repair.

  • Recovery time

    weight 0.70

    Faster return-to-activity in joint-pain cohorts.

  • Gut health & inflammation

    weight 0.40

    Systemic anti-inflammatory mechanism overlap (BPC-157 lane).

Evidence matrix

Outcome × ingredient signal — backed by indexed studies.

Each cell shows the clinical signal status and the count of indexed studies for that ingredient × outcome pair. Click any cell to open the ingredient brief.

Outcome \ IngredientBPC-157TB-500KPVTesamorelinIpamorelinCJC-1295 (with DAC)CJC-1295 (no DAC)SermorelinMK-677GHK-Cu
Tissue & joint repair····
Recovery time·········
Gut health & inflammation···
04Canonical, evidence-anchored

Matched protocol templates for this condition.

Matching templates…

Reported substances

What cohorts have used — and at what tier of evidence.

Suggestive, never prescriptive. Mydosage does not recommend a dose, a substance or a protocol. Decisions belong with you and a clinician.